Drugs Xagena

Xagena Mappa
Xagena Newsletter

Search results for "Xofigo"

Bayer HealthCare has announced that the FDA ( Food and Drug Administration ) has approved Xofigo ( Radium 223 dichloride ) for the treatment of patients with castration-resistant prostate cancer ( CRP ...

Xofigo is a radiopharmaceutical ( a medicine containing a radioactive substance ) that contains the active substance Radium-223 dichloride. It is used to treat adult men with cancer of the prostate. X ...

The Chemotherapy Clinical Reference Group ( CRG ) has reviewed drugs and drug indications for inclusion on the National cancer drugs fund list. The decision summaries record how each drug/drug indica ...